Clemens Röhrl Selected Research

high density lipoprotein receptors

3/2019	Loss of SR-BI Down-Regulates MITF and Suppresses Extracellular Vesicle Release in Human Melanoma.
1/2018	Malignant Phenotypes in Metastatic Melanoma are Governed by SR-BI and its Association with Glycosylation and STAT5 Activation.
8/2015	The HDL receptor SR-BI is associated with human prostate cancer progression and plays a possible role in establishing androgen independence.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Clemens Röhrl Research Topics

Disease

5	Neoplasms (Cancer) 01/2022 - 01/2011
4	Cardiovascular Diseases (Cardiovascular Disease) 11/2021 - 10/2016
3	Atherosclerosis 02/2024 - 11/2013
3	Melanoma (Melanoma, Malignant) 03/2019 - 12/2017
2	Adenocarcinoma 01/2022 - 01/2014
2	Carcinoma (Carcinomatosis) 05/2018 - 01/2014
2	Colorectal Neoplasms (Colorectal Cancer) 01/2014 - 01/2011
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022
1	Lung Neoplasms (Lung Cancer) 01/2020
1	Intellectual Disability (Idiocy) 01/2020
1	Spontaneous Abortion (Miscarriage) 11/2019
1	Habitual Abortion (Recurrent Miscarriage) 11/2019
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 10/2019
1	Obesity 01/2019
1	Colonic Neoplasms (Colon Cancer) 05/2018
1	Neoplasm Metastasis (Metastasis) 01/2018
1	Chronic Renal Insufficiency 09/2015
1	Prostatic Neoplasms (Prostate Cancer) 08/2015
1	Inflammation (Inflammations) 01/2014
1	Hepatocellular Carcinoma (Hepatoma) 02/2011

Drug/Important Bio-Agent (IBA)

11	CholesterolIBA 02/2024 - 11/2013
3	LipidsIBA 01/2022 - 02/2011
3	HDL LipoproteinsIBA 01/2022 - 01/2018
3	high density lipoprotein receptorsIBA 03/2019 - 08/2015
2	LDL Lipoproteins (beta Lipoproteins)IBA 11/2021 - 10/2019
2	Scavenger Receptors (Scavenger Receptor)IBA 03/2019 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 08/2015 - 01/2014
1	LDL CholesterolIBA 11/2021
1	Fatty Acid Synthases (Fatty Acid Synthase)IBA 01/2020
1	ponatinibIBA 01/2020
1	Progesterone FDA LinkGeneric 11/2019
1	Apolipoproteins B (ApoB)IBA 10/2019
1	Lipoproteins (Lipoprotein)IBA 10/2019
1	oxidized low density lipoproteinIBA 10/2019
1	AlkaloidsIBA 01/2019
1	BerberineIBA 01/2019
1	dendrotoxin AIBA 05/2018
1	STAT5 Transcription FactorIBA 01/2018
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 12/2017
1	AndrogensIBA 08/2015
1	Messenger RNA (mRNA)IBA 08/2015
1	Glucose (Dextrose)FDA LinkGeneric 04/2015
1	ciglitazoneIBA 01/2014
1	2,4-thiazolidinedione (thiazolidinedione)IBA 01/2014
1	Adenosine Triphosphate (ATP)IBA 02/2011
1	SphingomyelinsIBA 02/2011
1	4,4- difluoro- 4- bora- 3a,4a- diaza- s- indacene (BODIPY)IBA 02/2011
1	CeramidesIBA 02/2011
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2011
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2011
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2011

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 01/2022
1	Injections 01/2022
1	Castration 08/2015
1	Aftercare (After-Treatment) 01/2014